This fragile X awareness month, the NIH has renewed funding for a key study of the neurodegenerative condition fragile X-associated tremor ataxia syndrome (FXTAS).
A new Alzheimer’s drug is expected to be approved by the Food and Drug Administration (FDA). However, the medication works best mostly for those in the earliest stages of Alzheimer’s.
Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, but remained high for those living at home.
FDA approval of Opill will allow consumers to buy birth control pills without a prescription at drug stores, convenience stores, grocery stores and online.
